Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q1 2025 (March 31)3holders −1
0new positions
1sold out
$12.89avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Nomura Holdings Inc. ($29.4M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($1.7M) and Bank of New York Mellon Corp ($230K).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $771K |
All 13F filers, Q4 2024 → Q1 2025: 688,669 shares sold, net −688,669 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Nomura Holdings Inc. | 0.16% | Reduce -5.4% | 730,904 | $29.4M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 1,500,000 | $1.7M |
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $230K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.